LGND Market Cap & Key Metrics
Ligand Pharmaceuticals Incorporated
$294.99
-$8.54(-2.81%)
69
Overall
75
Value
63
Tech
71
Quality
Market Cap
$5.88B
Volume
245.28K
52W Range
$175.89 - $326.63
Target Price
$344.25
LGND market cap is $5.88B. This page lists Ligand Pharmaceuticals Incorporated's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
LGND Key Metrics
- Market cap
- $5.88B
- P/E ratio (current-year EPS estimate)
- 56.19
- EPS estimate, current year
- $5.25
- EPS growth, 3-year
- +73.83%
- Value score
- 75
- Quality score
- 71
- Technical score
- 63
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $268.09M | $167.13M | $131.31M | $196.25M | $241.54M |
| EBITDA | $198.72M | $41.28M | $101.08M | $89.91M | $159.46M |
| EPS | $6.44 | $-1.64 | $3.02 | $-1.98 | $2.15 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $294.99 | -2.8% | 245.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW